505 related articles for article (PubMed ID: 11713228)
1. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
[TBL] [Abstract][Full Text] [Related]
2. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
Pezet A; Favre H; Kelly PA; Edery M
J Biol Chem; 1999 Aug; 274(35):24497-502. PubMed ID: 10455112
[TBL] [Abstract][Full Text] [Related]
4. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
[TBL] [Abstract][Full Text] [Related]
5. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
6. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL
J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320
[TBL] [Abstract][Full Text] [Related]
8. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
Ram PA; Waxman DJ
J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
[TBL] [Abstract][Full Text] [Related]
10. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
Ram PA; Waxman DJ
J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
[TBL] [Abstract][Full Text] [Related]
11. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
Ali S; Nouhi Z; Chughtai N; Ali S
J Biol Chem; 2003 Dec; 278(52):52021-31. PubMed ID: 14522994
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
14. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
15. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2.
Leung KC; Doyle N; Ballesteros M; Sjogren K; Watts CK; Low TH; Leong GM; Ross RJ; Ho KK
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1016-21. PubMed ID: 12552091
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
[TBL] [Abstract][Full Text] [Related]
17. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
Ali S; Ali S
J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
[TBL] [Abstract][Full Text] [Related]
18. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Ling C; Billig H
Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
[TBL] [Abstract][Full Text] [Related]
19. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]